Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Respiratory Viral Infection
In brief
The goal of this phase III study is to learn if JKN2301 Dry Suspension works to treat uncomplicated influenza in Pediatric Participants aged 2 to 11 years.
Key facts
- Study ID
- NCT07357051
- Run by
- Joincare Pharmaceutical Group Industry Co., Ltd
- People needed
- 177
- Starts
- 2025-11-07
- Expected to finish
- 2026-04-15
- Last updated by the study team
- 2026-01-21
Who can join
Age: 2 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Pediatric patients within the specified age range.
- Clinical presentation consistent with influenza, confirmed by a positive local rapid test or central laboratory PCR test.
- Presentation for treatment within the early symptomatic phase of influenza illness.
- Presence of fever and at least one respiratory symptom.
- Ability to swallow oral suspension.
- Parent/guardian and patient (as age-appropriate) able to provide informed consent/assent.
You may not qualify if…
- Clinical signs suggestive of severe or complicated influenza infection
- requiring inpatient management.
- Presence of a concurrent bacterial infection requiring systemic therapy.
- Significant immunocompromised, or severe/uncontrolled comorbid conditions.
- History of hypersensitivity to any component of the investigational products.
- Use of prohibited medications (including other anti-influenza antivirals) within a specified period prior to enrollment.
- Recent participation in another interventional clinical trial.
- Any condition that, in the opinion of the investigator, would jeopardize patient safety or compliance with the study protocol.
Where it is running
- First Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.